Delivery Order SPE2DB25D3504-SPE2DB25FVVHT
Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Timolol 0.5% Gel-Solution, a prescription eye medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,356.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award is for the delivery of Timolol 0.5% gel-solution, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,618.94 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a $4,652.73 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.5% Gel-Solution 5ml, a prescription medication, with a completion date of July 11, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of TIMOLOL 0.5% GEL-SOLUTION 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,402.46 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2024. The contract has a completion date of December 17, 2024 and is a Firm Fixed Price Delivery Order. The contract is not associated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Timolol 0.5% gel-solution, a pharmaceutical product used for the treatment of glaucoma. The contract has a ceiling value of $2,026.35 and a completion date of March 27, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,104.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4566293145 units of Timolol 0.5% Gel-Solution 5ML. The contract has an ultimate completion date of November 1, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09, UEI: KABZK8W6PQT3) is for the supply of Timolol 0.5% Gel-Solution 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $4,941.61 and is a Delivery Order under a broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of Timolol 0.5% gel-solution, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order contract. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,945.87 and a completion date of April 19, 2022. The award was made on April 18, 2022, and there was no set-aside designation, indicating an open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,147.89, is for the delivery of TIMOLOL 0.25% GEL-SOLUTION 5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Timolol 0.5% Gel-Solution, a pharmaceutical product, with a ceiling value of $4,786.14. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order (DO) type with a Firm Fixed Price (FFP) pricing mechanism. The contract has an ultimate completion date of April 25, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical...